CorNeat Vision is an ophthalmic medical device company founded in 2015. We focus on the design, development, and commercialization of innovative and long-lasting ophthalmic solutions, which address trauma and disease. CorNeat Vision galvanizes unique design, materials, and medical procedures to provide revolutionary, long-lasting, durable, comfortable, aesthetic, affordable and easily accessible solutions to blindness and ophthalmic pathology.
CorNeat Vision's core technology will revolutionize ophthalmic (anterior chamber) surgery by introducing novel implants that mimic biological structures and functions and integrate with the surrounding tissue. Our patented implants are easily deployed and designed to provide long-term relief from diversified ophthalmic indications.
Experienced team with multi-disciplinary background
Scientific Advisory Board
CorNeat advisory board consists of the world’s top ophthalmologists and ophthalmic innovators in cornea, glaucoma, and anterior chamber devices and surgery. Together, they have published over 650 peer reviewed papers.
Our Scientific Advisory Board consists of key opinion leaders from Israel, Canada, US, France, and China, who are planned to take an active role in our planned clinical trials and subsequent regulatory submissions.